🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic malignancy.

“The shining star of our household has faded away for us in the present world,” his family stated. “After a prolonged and brave struggle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and collaborations with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on Billboard’s Top R&B Albums chart, earned platinum status later that year, and received several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record premiered at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the singer, famously bare to his midsection, performing straight into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the R&B chart and a award for Best R&B Album.

Once more, in his own enigmatic fashion, D’Angelo had limited public appearances in the following years.

The singer was scheduled as a headliner for the 2025 Roots Picnic festival, but his performance was called off, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the months before his death, he had apparently been hospitalized for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable types of the disease, on a brilliant talent whose existence was cut short.

“We are saddened that he can only provide dear memories with his family, but we are forever thankful for the legacy of deeply emotional music he has left us,” his family said.

Pancreatic Cancer: Lethal and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a tiny gland that generates the hormone insulin and plays an essential role in digestion, among additional roles. The size and location of the organ in the human system make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for 7% of cancer deaths.

Almost seventy thousand people will be found to have pancreatic cancer and roughly fifty-two thousand will succumb to the disease in 2025.

“This malignancy is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have limited and ineffective treatment options, and a smaller window to make a meaningful impact on the lives of people,” said a medical oncologist.

Because this disease rarely causes initial signs, it’s often diagnosed only once the disease is advanced. Even when a patient has symptoms they are usually vague and may be mistaken for a number of common illnesses.

“Currently, there is no effective method to detect pancreatic cancer in the early stages, except for paying attention to physical changes and speaking with your physician if there are new or unusual symptoms,” said a health expert.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• brownish urine
• light-colored or greasy stools
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in adults in the 65 to 75 age bracket. However, many cancers, including this type, have become more common among younger people.

“This disease diagnosed before the age of 50 is considered uncommon, yet concerningly, clinicians are beginning to see a growing number of younger individuals suffering from this disease,” commented a specialist.

Genetic Background Impacts Disease Probability

Without reliable detection methods for pancreatic cancer, experts emphasized the importance of knowing your family’s health background. Certain contributing elements, such as tobacco use and excess weight also play a role in the development of pancreatic cancer.

Black individuals have the highest incidence of this malignancy in the United States and are most likely to be diagnosed with inoperable cancer.

“The first step toward reducing one’s chance of this condition is assessing individual susceptibility. People should review their genetic background, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a specialist.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your family has had this disease, you may want to consider DNA analysis.

“For people with a relative’s background of this condition or those having high risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the pancreas,” he clarified.

For those looking to reduce their risk, lifestyle changes may have an effect. The most effective step you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, stay away altogether.

Heavy drinking is associated with pancreas inflammation, a contributing element for this malignancy, so reducing or abstaining from alcohol may assist lower your chance.

Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are twenty percent more prone to develop this disease. Pancreatic cancer also is more frequent in those with diabetes, and weight loss can also lower the risk of type 2 diabetes.

Despite this disease’s poor prognosis, there is still hope.

“We are making progress with therapies and newer combination chemotherapy. There are developing targeted therapies that already are showing results,” said a expert.

For numerous people, however, education about this rare but {dev